Holloway Wealth Management »

Regeneron Pharmaceuticals shares owned by Holloway Wealth Management

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Holloway Wealth Management from 13F filings

Historical chart of Holloway Wealth Management investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Holloway Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Holloway Wealth Management

Quarter filed Position value Share count Share price at filing
2022-03-31 $22k 31 709.68
2021-12-31 $20k 31 645.16
2021-09-30 $19k 31 612.90
2021-06-30 $17k 31 548.39
2021-03-31 $15k 31 483.87
2020-12-31 $15k 31 483.87
2020-09-30 $17k 31 548.39

More positions owned by Holloway Wealth Management

Horizon Active Risk Assist Fund Class N M (Principal) (ARANX)
Horizon Active Asset Allocation Fund Class N M (Principal) (AAANX)
Chevron Corporation (Principal) (CVX)
Cisco Systems (Principal) (CSCO)
Lockheed Martin Corporation (Principal) (LMT)
Wal-Mart Stores (Principal) (WMT)
First Tr Exchange-traded First Tr Enh New (Principal) (FTSM)
Altria (Principal) (MO)
BlackRock (Principal)
Apple (Principal) (AAPL)
Unilever Spon Adr New (Principal)
Pepsi (Principal) (PEP)
Taiwan Semiconductor Mfg Sponsored Ads (Principal) (TSM)
General Dynamics Corporation (Principal) (GD)
Bristol Myers Squibb (Principal) (BMY)

View all positions for Holloway Wealth Management

Top funds holding Regeneron Pharmaceuticals

Vanguard Group
BlackRock
State Street Corporation
Dodge & Cox
Jpmorgan Chase & Co
Franklin Resources
Geode Capital Management
Nuveen
FMR
Loomis, Sayles and
Invesco
Capital World Investors
Susquehanna International
Goldman Sachs Group
Norges Bank Investment Management

View all funds holding Regeneron Pharmaceuticals